57
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The 5p15.33 Locus Is Associated with Risk of Lung Adenocarcinoma in Never-Smoking Females in Asia

      research-article
      1 , * , 2 , * , 3 , 4 , 5 , 6 , 2 , 7 , 2 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 1 , 18 , 19 , 20 , 21 , 22 , 2 , 23 , 24 , 25 , 26 , 27 , 2 , 14 , 1 , 28 , 29 , 21 , 30 , 27 , 22 , 9 , 3 , 1 , 31 , 3 , 4 , 14 , 32 , 15 , 21 , 2 , 9 , 15 , 33 , 10 , 14 , 16 , 34 , 35 , 21 , 2 , 15 , 9 , 1 , 18 , 19 , 21 , 11 , 18 , 20 , 2 , 23 , 24 , 36 , 31 , 14 , 2 , 23 , 18 , 19 , 20 , 10 , 2 , 30 , 26 , 2 , 32 , 33 , 34 , 8 , 37 , 11 , 6 , 1 , 1 , 2 , 2 , 23 , 38 , 30 , 2 , 9
      PLoS Genetics
      Public Library of Science

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Genome-wide association studies of lung cancer reported in populations of European background have identified three regions on chromosomes 5p15.33, 6p21.33, and 15q25 that have achieved genome-wide significance with p-values of 10 −7 or lower. These studies have been performed primarily in cigarette smokers, raising the possibility that the observed associations could be related to tobacco use, lung carcinogenesis, or both. Since most women in Asia do not smoke, we conducted a genome-wide association study of lung adenocarcinoma in never-smoking females (584 cases, 585 controls) among Han Chinese in Taiwan and found that the most significant association was for rs2736100 on chromosome 5p15.33 (p = 1.30×10 −11). This finding was independently replicated in seven studies from East Asia totaling 1,164 lung adenocarcinomas and 1,736 controls (p = 5.38×10 −11). A pooled analysis achieved genome-wide significance for rs2736100. This SNP marker localizes to the CLPTM1L- TERT locus on chromosome 5p15.33 (p = 2.60×10 −20, allelic risk = 1.54, 95% Confidence Interval (CI) 1.41–1.68). Risks for heterozygote and homozygote carriers of the minor allele were 1.62 (95% CI; 1.40–1.87), and 2.35 (95% CI: 1.95–2.83), respectively. In summary, our results show that genetic variation in the CLPTM1L-TERT locus of chromosome 5p15.33 is directly associated with the risk of lung cancer, most notably adenocarcinoma.

          Author Summary

          Worldwide, approximately 15% of lung cancer cases occur among nonsmokers. Genome-wide association studies (GWAS) of lung cancer conducted in populations of European background have identified three regions on chromosomes 5, 6, and 15 that harbor genetic variants that confer risk for lung cancer. Prior studies were conducted primarily in cigarette smokers, raising the possibility that the associations could be related to tobacco use, lung carcinogenesis, or both. A GWAS of lung cancer among never-smokers is an optimal setting to discover effects that are independent of smoking. Since most women in Asia do not smoke, we conducted a GWAS of lung adenocarcinoma among never-smoking females (584 cases, 585 controls) in Taiwan, and observed a region on chromosome 5 significantly associated with risk for lung cancer in never-smoking women. The finding was independently replicated in seven studies from East Asia totaling 1,164 lung adenocarcinomas and 1,736 controls. To our knowledge, this study is the first reported GWAS of lung cancer in East Asian women, and together with the replication studies represents the largest genetic association study in this population. The findings provide insight into the genetic contribution of common variants to lung carcinogenesis.

          Related collections

          Most cited references26

          • Record: found
          • Abstract: found
          • Article: not found

          Obesity, cigarette smoking, and telomere length in women.

          Obesity and smoking are important risk factors for many age-related diseases. Both are states of heightened oxidative stress, which increases the rate of telomere erosion per replication, and inflammation, which enhances white blood cell turnover. Together, these processes might accelerate telomere erosion with age. We therefore tested the hypothesis that increased body mass and smoking are associated with shortened telomere length in white blood cells. We investigated 1122 white women aged 18-76 years and found that telomere length decreased steadily with age at a mean rate of 27 bp per year. Telomeres of obese women were 240 bp shorter than those of lean women (p=0.026). A dose-dependent relation with smoking was recorded (p=0.017), and each pack-year smoked was equivalent to an additional 5 bp of telomere length lost (18%) compared with the rate in the overall cohort. Our results emphasise the pro-ageing effects of obesity and cigarette smoking.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1.

            To identify risk variants for lung cancer, we conducted a multistage genome-wide association study. In the discovery phase, we analyzed 315,450 tagging SNPs in 1,154 current and former (ever) smoking cases of European ancestry and 1,137 frequency-matched, ever-smoking controls from Houston, Texas. For replication, we evaluated the ten SNPs most significantly associated with lung cancer in an additional 711 cases and 632 controls from Texas and 2,013 cases and 3,062 controls from the UK. Two SNPs, rs1051730 and rs8034191, mapping to a region of strong linkage disequilibrium within 15q25.1 containing PSMA4 and the nicotinic acetylcholine receptor subunit genes CHRNA3 and CHRNA5, were significantly associated with risk in both replication sets. Combined analysis yielded odds ratios of 1.32 (P < 1 x 10(-17)) for both SNPs. Haplotype analysis was consistent with there being a single risk variant in this region. We conclude that variation in a region of 15q25.1 containing nicotinic acetylcholine receptors genes contributes to lung cancer risk.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25.

              Lung cancer is the most common cause of cancer death worldwide, with over one million cases annually. To identify genetic factors that modify disease risk, we conducted a genome-wide association study by analysing 317,139 single-nucleotide polymorphisms in 1,989 lung cancer cases and 2,625 controls from six central European countries. We identified a locus in chromosome region 15q25 that was strongly associated with lung cancer (P = 9 x 10(-10)). This locus was replicated in five separate lung cancer studies comprising an additional 2,513 lung cancer cases and 4,752 controls (P = 5 x 10(-20) overall), and it was found to account for 14% (attributable risk) of lung cancer cases. Statistically similar risks were observed irrespective of smoking status or propensity to smoke tobacco. The association region contains several genes, including three that encode nicotinic acetylcholine receptor subunits (CHRNA5, CHRNA3 and CHRNB4). Such subunits are expressed in neurons and other tissues, in particular alveolar epithelial cells, pulmonary neuroendocrine cells and lung cancer cell lines, and they bind to N'-nitrosonornicotine and potential lung carcinogens. A non-synonymous variant of CHRNA5 that induces an amino acid substitution (D398N) at a highly conserved site in the second intracellular loop of the protein is among the markers with the strongest disease associations. Our results provide compelling evidence of a locus at 15q25 predisposing to lung cancer, and reinforce interest in nicotinic acetylcholine receptors as potential disease candidates and chemopreventative targets.
                Bookmark

                Author and article information

                Contributors
                Role: Editor
                Journal
                PLoS Genet
                plos
                plosgen
                PLoS Genetics
                Public Library of Science (San Francisco, USA )
                1553-7390
                1553-7404
                August 2010
                August 2010
                5 August 2010
                : 6
                : 8
                : e1001051
                Affiliations
                [1 ]Division of Biostatistics and Bioinformatics, Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Taiwan
                [2 ]Division of Cancer Epidemiology, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America
                [3 ]Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
                [4 ]Institute of Environmental Medicine, Seoul National University Medical Research Center, Seoul, Republic of Korea
                [5 ]Genomics Research Center, Academia Sinica, Taipei, Taiwan
                [6 ]Graduate Institute of Epidemiology, College of Public Health, National Taiwan University, Taipei, Taiwan
                [7 ]National Institute of Cancer Research, National Health Research Institutes, Zhunan, Taiwan
                [8 ]International Agency for Research on Cancer, Lyon, France
                [9 ]Departments of Etiology and Carcinogenesis and State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
                [10 ]Department of Medicine, Vanderbilt Epidemiology Center, Institute for Medicine and Public Health, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America
                [11 ]Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan
                [12 ]Institute of Biomedical Sciences, National Chung-Hsing University, Taichung, Taiwan
                [13 ]School of Medicine, China Medical University, Taichung, Taiwan
                [14 ]Institute of Occupational Medicine and Ministry of Education Key Lab for Environment and Health, School of Public Health, Huazhong University of Science and Technology, Wuhan, China
                [15 ]Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea
                [16 ]Department of Biochemistry, School of Medicine, Kyungpook National University, Daegu, Republic of Korea
                [17 ]Cancer Research Center, Kyungpook National University Hospital, Daegu, Republic of Korea
                [18 ]Genomic Research Center for Lung and Breast/Ovarian Cancers, Korea University Anam Hospital, Seoul, Republic of Korea
                [19 ]Department of Internal Medicine and Division of Brain, Korea University College of Medicine, Seoul, Republic of Korea
                [20 ]Division of Oncology/Hematology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea
                [21 ]Department of Epidemiology and Biostatistics, Cancer Center, Nanjing Medical University, Nanjing, China
                [22 ]Department of Epidemiology and Public Health, National University of Singapore, Singapore, Singapore
                [23 ]Core Genotyping Facility, Advanced Technology Program, Science Applications International Corporation-Frederick, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Frederick, Maryland, United States of America
                [24 ]Department of Pulmonary and Critical Care, Chang Gung Memorial Hospital, Taiwan
                [25 ]Department of Respiratory Care, Chang Gung University, Taiwan
                [26 ]Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea
                [27 ]Department of Thoracic and Cardiovascular Surgery, Clinical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea
                [28 ]Department of Thoracic and Cardiovascular Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea
                [29 ]Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital, Geongi-do, Republic of Korea
                [30 ]Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
                [31 ]Department of Epidemiology, Shanghai Cancer Institute, Shanghai, China
                [32 ]Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
                [33 ]Department of Internal Medicine, National Cheng Kung University Hospital and College of Medicine, Tainan, Taiwan
                [34 ]Chest Department, Taipei Veterans General Hospital, Taipei, Taiwan
                [35 ]School of Medicine, National Yang-Ming University, Taipei, Taiwan
                [36 ]Department of Internal Medicine, Inha University College of Medicine, Incheon, Republic of Korea
                [37 ]Cancer Center, China Medical University Hospital, Taipei, Taiwan
                [38 ]Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America
                University of Alabama at Birmingham, United States of America
                Author notes

                Conceived and designed the experiments: CAH QL CJC ISC NC JYP YHK AS YTK JHK ISK JFFJ SJC PCY NR DL. Performed the experiments: CAH YCH CW TW HS MY YC JHK JSS JY AH SYY CYH SJC DL. Analyzed the data: CAH QL HDHI ISC NC CFH MY WCW YLL CHC JSS CKC SJC NR. Contributed reagents/materials/analysis tools: CAH QL YCH CJC HDHI NC PB CW WZ GCC TW YHK HS MY YHT YTK WHC HG SWS ZH KYC JHK LH KML YTG LL MSH THJ GJ NC DY CHK WCS XOS PX YMC HM MS SIC WT MZ TYY KHP JY CLW JSR YX QD AH JSK QC MTL CJY JYP MT JYH CCL RPP PB CYC KCC JFFJ SJC PCY NR DL. Wrote the paper: CAH QL YCH ISC. Manuscript revision: YCH DH CN PB AS MY WHC YTG NEC XOS MS JY AH QC MT JF SJC NR.

                ¶ These authors were joint senior authors on this work.

                Article
                09-PLGE-RA-1867R3
                10.1371/journal.pgen.1001051
                2916850
                20700438
                445bab7a-2004-4e70-baf2-ae246adffdab
                This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
                History
                : 26 October 2009
                : 7 July 2010
                Page count
                Pages: 9
                Categories
                Research Article
                Genetics and Genomics
                Genetics and Genomics/Cancer Genetics

                Genetics
                Genetics

                Comments

                Comment on this article